Patents by Inventor Tae Lim Kim
Tae Lim Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11355006Abstract: Disclosed is a crosswalk system according to various embodiments comprising an infrastructure including a communication device, a vehicle communicating with the infrastructure, and an indicating device electrically connected to the infrastructure. The infrastructure may detect an external object within a predetermined area through at least one sensor, obtain a location of the vehicle through the communication device, and based on the detected external object and the obtained position of the vehicle, transmit to the indicating device a signal requesting provision of information related to whether it is possible to cross the predetermined area from the external object or the vehicle. Other various embodiment may be implemented.Type: GrantFiled: August 12, 2021Date of Patent: June 7, 2022Assignee: KOREA AUTOMOTIVE TECHNOLOGY INSTITUTEInventors: Hyun Woo Cho, Ho Joon Kang, Tae Lim Kim, Seong-Jin Kwon, Seok-San Shin, Ju Yeon Hwang
-
Patent number: 9758571Abstract: There are provided peptide tags derived from bacteriophytochrome (BphP) that is photoreceptor protein of Deinococcus radiodurans, an antibody capable of specifically recognizing the peptide tags, hybridoma cell lines capable of producing the antibody, and uses thereof. The novel peptide tag has advantages in that it has a short length and can remove a non-specific reaction of the conventional c-myc tag and FLAG tag. Therefore, in the case of using the novel peptide tag and antibody thereto, the fusion protein expressed in a recombinant cell can be very effectively detected or purified. In addition, an epitope tagging system including the novel peptide tag and antibody thereto can be applied in various fields such as a determination of an intracellular site, a confirmation of functionality, detection and purification of specific protein, and researches on interaction between proteins.Type: GrantFiled: June 20, 2013Date of Patent: September 12, 2017Assignees: University—Industry Cooperation Group Of Kyung Hee University, Myongji University Industry and Academia Cooperation FoundationInventors: Seong Hee Bhoo, Tae Ryong Hahn, Tae Lim Kim, Joo Won Suh, Seung Hwan Yang
-
Patent number: 9580479Abstract: There are provided peptide tags derived from bacteriophytochrome (BphP) that is photoreceptor protein of Deinococcus <i/> radiodurans, an antibody capable of specifically recognizing the peptide tags, hybridoma cell lines capable of producing the antibody, and uses thereof. The novel peptide tag has advantages in that it has a short length and can remove a non-specific reaction of the conventional c-myc tag and FLAG tag. Therefore, in the case of using the novel peptide tag and antibody thereto, the fusion protein expressed in a recombinant cell can be very effectively detected or purified. In addition, an epitope tagging system including the novel peptide tag and antibody thereto can be applied in various fields such as a determination of an intracellular site, a confirmation of functionality, detection and purification of specific protein, and researches on interaction between proteins.Type: GrantFiled: June 20, 2013Date of Patent: February 28, 2017Assignees: University—Industry Cooperation Group of Kyung Hee University, Myongji University Industry and Academia Cooperation FoundationInventors: Seong Hee Bhoo, Tae Ryong Hahn, Tae Lim Kim, Joo Won Suh, Seung Hwan Yang
-
Publication number: 20150191532Abstract: There are provided peptide tags derived from bacteriophytochrome (BphP) that is photoreceptor protein of Deinococcusradiodurans, an antibody capable of specifically recognizing the peptide tags, hybridoma cell lines capable of producing the antibody, and uses thereof. The novel peptide tag has advantages in that it has a short length and can remove a non-specific reaction of the conventional c-myc tag and FLAG tag. Therefore, in the case of using the novel peptide tag and antibody thereto, the fusion protein expressed in a recombinant cell can be very effectively detected or purified. In addition, an epitope tagging system including the novel peptide tag and antibody thereto can be applied in various fields such as a determination of an intracellular site, a confirmation of functionality, detection and purification of specific protein, and researches on interaction between proteins.Type: ApplicationFiled: June 20, 2013Publication date: July 9, 2015Applicant: Myongi University Industry and Academai Cooperatio FoundationInventors: Seong Hee Bhoo, Tae Ryong Hahn, Tae Lim Kim, Joo Won Suh, Seung Hwan Yang
-
Publication number: 20150175669Abstract: There are provided peptide tags derived from bacteriophytochrome (BphP) that is photoreceptor protein of Deinococcus <i/> radiodurans, an antibody capable of specifically recognizing the peptide tags, hybridoma cell lines capable of producing the antibody, and uses thereof. The novel peptide tag has advantages in that it has a short length and can remove a non-specific reaction of the conventional c-myc tag and FLAG tag. Therefore, in the case of using the novel peptide tag and antibody thereto, the fusion protein expressed in a recombinant cell can be very effectively detected or purified. In addition, an epitope tagging system including the novel peptide tag and antibody thereto can be applied in various fields such as a determination of an intracellular site, a confirmation of functionality, detection and purification of specific protein, and researches on interaction between proteins.Type: ApplicationFiled: June 20, 2013Publication date: June 25, 2015Applicant: University- Industry Cooperation Group of Kyung Hee UniversityInventors: Seong Hee Bhoo, Tae Ryong Hahn, Tae Lim Kim, Joo Won Suh, Seung Hwan Yang
-
Patent number: 8343940Abstract: Disclosed herein is a method for enhancing sensitivity of cancer cells to compounds or radiation by inhibiting the expression of testis-specific protein, Y-encoded like 5 (TSPYL5). More specifically, because methylation of TSPYL5 protein expressed in lung cancer cell line was inhibited to increase the expression level of the gene, resistance to stress such as radiation or anticancer agents was increased. Because the sensitivity of cancer cells to stress such as radiation or anticancer agents was increased by inhibiting the expression of the TSPYL5 gene to promote the apoptosis of the cells, an anticancer supplement agent containing an inhibitor of the expression or activity of the TSPYL5 gene of the present invention inhibits the growth of cancer cells and enhances the sensitivity to various stresses to maximize the apoptosis. Thus, when used in combination with radiotherapy or chemotherapy, the anticancer supplement agent may be used very usefully for anticancer treatment.Type: GrantFiled: June 24, 2010Date of Patent: January 1, 2013Assignee: Korea Atomic Energy Research InstituteInventors: In Gyu Kim, Tae Lim Kim, Kug Chan Kim, Eun Jin Kim, So Yong Lee, Il Lae Jung
-
Publication number: 20110111400Abstract: Disclosed herein is a method for enhancing sensitivity of cancer cells to compounds or radiation by inhibiting the expression of testis-specific protein, Y-encoded like 5 (TSPYL5). More specifically, because methylation of TSPYL5 protein expressed in lung cancer cell line was inhibited to increase the expression level of the gene, resistance to stress such as radiation or anticancer agents was increased. Because the sensitivity of cancer cells to stress such as radiation or anticancer agents was increased by inhibiting the expression of the TSPYL5 gene to promote the apoptosis of the cells, an anticancer supplement agent containing an inhibitor of the expression or activity of the TSPYL5 gene of the present invention inhibits the growth of cancer cells and enhances the sensitivity to various stresses to maximize the apoptosis. Thus, when used in combination with radiotherapy or chemotherapy, the anticancer supplement agent may be used very usefully for anticancer treatment.Type: ApplicationFiled: June 24, 2010Publication date: May 12, 2011Applicant: Korea Atomic Energy Research InstituteInventors: In Gyu KIM, Tae Lim Kim, Kug Chan Kim, Eun Jin Kim, So Yong Lee, Il Lae Jung